21 CFR 522.454
§ 522.454 Clodronate.
United States · 21 CFR — Food and Drugs · Status: effective
Cite this
- Citation
- 21 CFR 522.454, § 522.454 Clodronate, United States, version 1 as recorded 2026-07-09, yourstate.us, https://yourstate.us/provision/87409
- Permanent ID
ys:prov:87409@1- SHA-256
53c79c90e5a6f0259c6911b186201786c898e502dc39ab6bbdf351afcaaa6d19
The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.
Full text
(a) Specifications. Each milliliter of solution contains 60 milligrams (mg) clodronate disodium.
(b) Sponsor. See No. 043264 in § 510.600(c) of this chapter.
(c) Conditions of use in horses—(1) Amount. Administer 1.8 mg per kilogram of body weight by intramuscular injection up to a maximum dose of 900 mg per horse.
(2) Indications for use. For the control of clinical signs associated with navicular syndrome.
(3) Limitations. Do not use in horses intended for human consumption. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Legislative history
This is a federal regulation, adopted through agency rulemaking under the Administrative Procedure Act — not enacted by a recorded vote of Congress.